Pet Imaging News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innovations in the detection, diagnosis, and risk assessment of suspicious tumors and risk assessment are expected to stimulate the PET radiotracer market.Wilmington, Delaware, United States, July 28, 2023 (GLOBE NEWSWIRE) -- According to TMR, PET radiotracers are expected to rise at a CAGR of 8.5% by 2031. A recent market study estimates that, by 2031, the global PET radiotracer market is expected to reach US$ 3.2 billion. Oncology and neuroscience are the primary fields in which PET radiotrace

Dublin, April 06, 2023 (GLOBE NEWSWIRE) -- The "2023 U.S PET Imaging Market Summary Report" report has been added to ResearchAndMarkets.com's offering. ...

Researchers have developed an artificial intelligence (AI) deep-learning model that may help clinicians diagnose parkinsonian diseases.

Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "Global PET-CT Scanner Device Market Size, Share & Industry Trends Analysis Report By Slice Count, By...

Molecular Imaging Assess Breast Cancer Treatment Efficacy by Angela Mohan on  February 17, 2021 at 12:11 PM Journal of Nuclear Medicine. Nearly two-thirds of invasive breast cancers are ER-positive, and endocrine therapy is the mainstay of treatment for these tumors because of its favorable toxicity profile and efficacy. Should cancer progress in these patients, however, salvage endocrine therapy with molecularly targeted agents or chemotherapy can help. "In some ER-positive breast cancer patients, cancer progression can be a result of a gradual resistance to endocrine ther...